US54142F1021 - LOGC - A2N7B4 (XNMS)
LOGICBIO THERAPEUTICSCS INC Aktie
5,42 USD
Aktuelle Kurse von LOGICBIO THERAPEUTICSCS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
LOGC
|
USD
|
19.09.2024 21:59
|
5,42 USD
| 5,37 USD | 0,84 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 3,45 % | -2,43 % | -4,16 % | 161,59 % | 161,59 % | -46,86 % |
Firmenprofil zu LOGICBIO THERAPEUTICSCS INC Aktie
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. As of November 15, 2022, LogicBio Therapeutics, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc..
Unternehmensdaten zur LOGICBIO THERAPEUTICSCS INC Aktie
Name LOGICBIO THERAPEUTICSCS INC
Firma LogicBio Therapeutics, Inc.
Symbol LOGC
Website https://www.logicbio.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A2N7B4
ISIN US54142F1021
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Rishi Bajaj
Marktkapitalisierung 136 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,5 T
Adresse 65 Hayden Ave, 2Nd Floor, 02421 Lexington
IPO Datum 2018-10-19
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
13.05.2024 | WISH | LOGC |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | LOGC |
Weitere Aktien
Investoren die LOGICBIO THERAPEUTICSCS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024